Acadian Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,670
| Closed | -$29K | – | 1877 |
|
|
2023
Q3 | $29K | Sell |
7,670
-1
| -0% | -$4 | ﹤0.01% | 1487 |
|
|
2023
Q2 | $53K | Sell |
7,671
-3,699
| -33% | -$25.6K | ﹤0.01% | 1524 |
|
|
2023
Q1 | $84K | Sell |
11,370
-1,325
| -10% | -$9.79K | ﹤0.01% | 1431 |
|
|
2022
Q4 | $91K | Buy |
12,695
+7,031
| +124% | +$50.4K | ﹤0.01% | 1459 |
|
|
2022
Q3 | $54K | Hold |
5,664
| – | – | ﹤0.01% | 1490 |
|
|
2022
Q2 | $109K | Buy |
+5,664
| New | +$109K | ﹤0.01% | 1339 |
|
|
2021
Q3 | – | Sell |
-2,293
| Closed | -$318K | – | 2096 |
|
|
2021
Q2 | $318K | Sell |
2,293
-2,614
| -53% | -$363K | ﹤0.01% | 1297 |
|
|
2021
Q1 | $1.03M | Buy |
4,907
+1,310
| +36% | +$274K | ﹤0.01% | 944 |
|
|
2020
Q4 | $598K | Buy |
3,597
+1,627
| +83% | +$270K | ﹤0.01% | 1171 |
|
|
2020
Q3 | $334K | Sell |
1,970
-290
| -13% | -$49.2K | ﹤0.01% | 1265 |
|
|
2020
Q2 | $375K | Buy |
2,260
+1,479
| +189% | +$245K | ﹤0.01% | 1292 |
|
|
2020
Q1 | $90K | Buy |
+781
| New | +$90K | ﹤0.01% | 1371 |
|